Related by context. Frequent words. (Click for all words.) 68 safety tolerability pharmacokinetics 68 pharmacokinetic profiles 67 dose regimens 67 pharmacodynamic 67 pharmacodynamics 66 nab paclitaxel 66 administered subcutaneously 66 efficacy 65 pharmacokinetic profile 65 active comparator 65 Pharmacokinetic 65 noninferiority 65 glatiramer acetate 64 tolerability profile 64 tolerability 64 tanespimycin 64 dosing regimens 64 tolerated dose MTD 64 MIRCERA 63 vicriviroc 63 plus prednisone 63 mycophenolate mofetil 63 pharmacokinetics 63 SCH # 63 antithrombotic 63 randomized Phase III 63 prospective randomized controlled 63 Azedra 62 pertuzumab 62 biologic therapy 62 antitumor activity 62 6R BH4 62 tipranavir 62 Phase 2b study 62 vandetanib 62 Secondary endpoints included 62 achieved statistical significance 62 placebo controlled studies 62 Secondary endpoints include 62 temsirolimus 62 double blinded placebo 62 dose escalation trial 62 Cloretazine R VNP#M 62 intravenously administered 61 ziprasidone 61 decitabine 61 mcg dose 61 pharmacokinetic 61 Phase 1b trial 61 Secondary endpoints 61 esomeprazole 61 phase IIa 61 rHuPH# 61 mg QD 61 pharmacokinetic properties 61 axitinib 61 Phase 2a trial 61 cangrelor 61 rNAPc2 61 etoposide 61 Phase 1a 61 Carfilzomib 61 TELCYTA 61 adalimumab 61 DAVANAT 61 Navelbine 61 dose cohorts 60 long acting beta2 60 IMC A# 60 Tolerability 60 eniluracil 60 fondaparinux 60 receptor antagonists 60 placebo controlled clinical 60 CA4P 60 octreotide 60 immunomodulator 60 GRN#L 60 azacitidine 60 Phase 1b 60 alvimopan 60 PXD# 60 mg kg dose 60 Phase IIa clinical 60 Fidaxomicin 60 SNRI 60 Phase Ia 60 ocrelizumab 60 PS# [001] 60 non inferiority 60 phase IIb 60 retinoid 60 prespecified 60 relapsed refractory multiple myeloma 59 QT prolongation 59 zileuton 59 Amrubicin 59 secondary efficacy endpoints 59 Cmax 59 Phase 1b clinical 59 mcg kg